These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3518475)

  • 21. Arrays of Candida albicans pseudohyphae that protect the organisms from neutrophil fungicidal mechanisms in experimental infections of mice.
    Sohnle PG; Hahn BL; Wagner DK
    J Med Vet Mycol; 1994; 32(1):21-30. PubMed ID: 8207620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed hypersensitivity to fungal antigens in mice. II. Molecular classes in immunogenic RNA extracts that transfer delayed hypersensitivity.
    Rifkind D; Frey JA; Petersen EA; Dinowitz M
    J Infect Dis; 1976 May; 133(5):523-32. PubMed ID: 57198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphocyte stimulation in Candida albicans infections.
    Frisk A; von Stedingk LV; Wasserman J
    Sabouraudia; 1974 Mar; 12(1):87-94. PubMed ID: 4210102
    [No Abstract]   [Full Text] [Related]  

  • 24. Infection and tissue repair of experimental cutaneous candidiasis in diabetic mice.
    Pupim ACE; Campois TG; Araújo EJA; Svidizinski TIE; Felipe I
    J Med Microbiol; 2017 Jun; 66(6):808-815. PubMed ID: 28604330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of delayed hypersensitivity responses in Mycobacterium lepraemurium infections in resistant and susceptible strains of mice.
    Alexander J; Curtis J
    Immunology; 1979 Mar; 36(3):563-7. PubMed ID: 374255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathological observations in experimental candida infection of sensitized guinea pigs.
    Isoda M
    Mycopathologia; 1985 Sep; 91(3):187-92. PubMed ID: 4058565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological features in a case of chronic granulomatous candidiasis and its treatment with transfer factor.
    Valdimarsson H; Wood CB; Hobbs JR; Holt PJ
    Clin Exp Immunol; 1972 Jun; 11(2):151-63. PubMed ID: 4557179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contact sensitivity to Candida albicans--comparative studies in man and animal (guinea-pig).
    Tagami H; Urano-Suehisa S; Hatchome N
    Br J Dermatol; 1985 Oct; 113(4):415-24. PubMed ID: 3904808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental cutaneous candidiasis in rodents; II. Role of the stratum corneum barrier and serum complement as a mediator of a protective infalmmatory response.
    Ray TL; Wuepper KD
    Arch Dermatol; 1978 Apr; 114(4):539-43. PubMed ID: 646364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel model of cutaneous candidiasis produced in prednisolone-treated guinea-pigs.
    Maebashi K; Itoyama T; Uchida K; Suegara N; Yamaguchi H
    J Med Vet Mycol; 1994; 32(5):349-59. PubMed ID: 7844701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary tissue resistance to Candida albicans in normal and in immunosuppressed mice.
    Nugent KM; Onofrio JM
    Am Rev Respir Dis; 1983 Nov; 128(5):909-14. PubMed ID: 6638681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokine expression induced by Candida albicans in a model of cutaneous candidosis based on reconstituted human epidermis.
    Schaller M; Mailhammer R; Korting HC
    J Med Microbiol; 2002 Aug; 51(8):672-676. PubMed ID: 12171298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The fate of experimental cutaneous candidiasis in guinea pigs under the suppressed polymorphonuclear leukocyte chemotaxis by colchicine.
    Miyachi Y; Horio T; Imamura S
    Arch Dermatol Res; 1981; 271(4):373-80. PubMed ID: 7332347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishment and comparison of delayed-type hypersensitivity models in the B₆C₃F₁ mouse.
    Smith MJ; White KL
    J Immunotoxicol; 2010; 7(4):308-17. PubMed ID: 20825253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exposure of mice to UV-B radiation suppresses delayed hypersensitivity to Candida albicans.
    Denkins Y; Fidler IJ; Kripke ML
    Photochem Photobiol; 1989 May; 49(5):615-9. PubMed ID: 2667002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 18β-glycyrrhetinic acid induces immunological adjuvant activity of Th1 against Candida albicans surface mannan extract.
    Kim J; Joo I; Kim H; Han Y
    Phytomedicine; 2013 Aug; 20(11):951-5. PubMed ID: 23746951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-17 plays a central role in initiating experimental Candida albicans infection in mouse corneas.
    Zhang H; Li H; Li Y; Zou Y; Dong X; Song W; Jia C; Li S; Xi H; Liu D; Wang Y
    Eur J Immunol; 2013 Oct; 43(10):2671-82. PubMed ID: 23843112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thymic conversion of Candida albicans from commensalism to pathogenism.
    Schoch EP
    Arch Dermatol; 1971 Mar; 103(3):311-9. PubMed ID: 5548278
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of a novel delayed-type hypersensitivity assay to Candida albicans in adult and neonatal rats.
    Thorn M; Hudson AW; Kreeger J; Kawabe TT; Bowman CJ; Collinge M
    J Immunotoxicol; 2015; 12(4):350-60. PubMed ID: 25412622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-33 priming regulates multiple steps of the neutrophil-mediated anti-Candida albicans response by modulating TLR and dectin-1 signals.
    Le HT; Tran VG; Kim W; Kim J; Cho HR; Kwon B
    J Immunol; 2012 Jul; 189(1):287-95. PubMed ID: 22661085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.